Laura E. Niklason, President, CEO and Director at Humacyte, Inc. (HUMA), sold 3,000,000 shares at $4.34 ($13.2M) on 2024-11-19, disclosed to the SEC on 2024-11-20.
Open-market sale of $13.2M HUMA by President, CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.44 | 811,172 | $3.6M | 27.3% |
| 2 | $4.44 | 811,172 | $3.6M | 27.3% |
| 3 | $4.34 | 427,459 | $1.9M | 14.0% |
| 4 | $4.34 | 427,459 | $1.9M | 14.0% |
| 5 | $4.40 | 261,369 | $1.2M | 8.7% |
| 6 | $4.40 | 261,369 |
| $1.2M |
| 8.7% |
| Total | $4.40 avg | 3,000,000 | $13.2M | 100% |
| Filing → |
| HUMA | SELL | 2024-09-11 | $4.7M | — | Filing → |
| HUMA | BUY | 2024-09-03 | $8K | — | Filing → |
| HUMA | SELL | 2024-08-29 | $11.4M | — | Filing → |